KR20110040870A - 코르티코트로핀 방출 인자 수용체 활성의 피라지논 조절제 - Google Patents

코르티코트로핀 방출 인자 수용체 활성의 피라지논 조절제 Download PDF

Info

Publication number
KR20110040870A
KR20110040870A KR1020117002253A KR20117002253A KR20110040870A KR 20110040870 A KR20110040870 A KR 20110040870A KR 1020117002253 A KR1020117002253 A KR 1020117002253A KR 20117002253 A KR20117002253 A KR 20117002253A KR 20110040870 A KR20110040870 A KR 20110040870A
Authority
KR
South Korea
Prior art keywords
crf
cyclopropyl
mmol
methoxyethyl
difluoromethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020117002253A
Other languages
English (en)
Korean (ko)
Inventor
리처드 에이. 하츠
비제이 티. 아후자
비베카난다 엠. 브루둘라
조앤 제이. 브론슨
Original Assignee
브리스톨-마이어스 스큅 컴퍼니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 브리스톨-마이어스 스큅 컴퍼니 filed Critical 브리스톨-마이어스 스큅 컴퍼니
Publication of KR20110040870A publication Critical patent/KR20110040870A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020117002253A 2008-07-31 2009-04-27 코르티코트로핀 방출 인자 수용체 활성의 피라지논 조절제 Withdrawn KR20110040870A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8523008P 2008-07-31 2008-07-31
US61/085,230 2008-07-31

Publications (1)

Publication Number Publication Date
KR20110040870A true KR20110040870A (ko) 2011-04-20

Family

ID=40651774

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117002253A Withdrawn KR20110040870A (ko) 2008-07-31 2009-04-27 코르티코트로핀 방출 인자 수용체 활성의 피라지논 조절제

Country Status (10)

Country Link
US (2) US7932256B2 (cg-RX-API-DMAC7.html)
EP (1) EP2303867B1 (cg-RX-API-DMAC7.html)
JP (1) JP5396474B2 (cg-RX-API-DMAC7.html)
KR (1) KR20110040870A (cg-RX-API-DMAC7.html)
CN (1) CN102171205B (cg-RX-API-DMAC7.html)
AR (1) AR072639A1 (cg-RX-API-DMAC7.html)
AU (1) AU2009277057A1 (cg-RX-API-DMAC7.html)
MX (1) MX2011000754A (cg-RX-API-DMAC7.html)
TW (1) TW201008926A (cg-RX-API-DMAC7.html)
WO (1) WO2010014280A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
CA2889044A1 (en) 2012-11-15 2014-05-22 Roche Innovation Center Copenhagen A/S Anti apob antisense conjugate compounds
CA2893801A1 (en) 2013-01-30 2014-08-07 F. Hoffmann-La Roche Ag Lna oligonucleotide carbohydrate conjugates
KR20210064407A (ko) 2014-01-21 2021-06-02 뉴로크린 바이오사이언시즈 인코퍼레이티드 선천성 부신 과형성 치료를 위한 crf1 수용체 길항제
PL3984523T3 (pl) 2018-12-07 2026-02-02 Neurocrine Biosciences, Inc. Antagonista receptora crf1, jego formulacje farmaceutyczne i postacie stałe do leczenia wrodzonego przerostu nadnerczy
US12383536B2 (en) 2019-09-27 2025-08-12 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods of use
IT201900021216A1 (it) 2019-11-14 2021-05-14 Isagro Spa Processo per la preparazione di derivati piridinici e corrispondenti piridil-formammidine
ES3039926T3 (en) 2019-12-04 2025-10-27 Neurocrine Biosciences Inc Crf receptor antagonists and methods of use
CN112552184B (zh) * 2020-12-18 2022-05-10 诚达药业股份有限公司 一种含环丙基手性胺盐酸盐的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4270297A (en) * 1996-09-16 1998-04-02 Du Pont Pharmaceuticals Company Pyrazinones and triazinones and their derivatives thereof
ATE307121T1 (de) * 2000-02-16 2005-11-15 Neurogen Corp Substituierte arylpyrazine
HRP20031096A2 (en) * 2001-06-12 2005-08-31 Neurogen Corporation 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
AU2003278542A1 (en) 2002-11-21 2004-06-15 Pharmacia & Upjohn Company Llc Pyrazine compounds as crf modulators

Also Published As

Publication number Publication date
TW201008926A (en) 2010-03-01
WO2010014280A1 (en) 2010-02-04
EP2303867B1 (en) 2014-12-17
MX2011000754A (es) 2011-02-24
US8372847B2 (en) 2013-02-12
JP2011529886A (ja) 2011-12-15
CN102171205B (zh) 2013-08-07
US20110166160A1 (en) 2011-07-07
AR072639A1 (es) 2010-09-08
US7932256B2 (en) 2011-04-26
JP5396474B2 (ja) 2014-01-22
AU2009277057A1 (en) 2010-02-04
CN102171205A (zh) 2011-08-31
US20100029684A1 (en) 2010-02-04
EP2303867A1 (en) 2011-04-06

Similar Documents

Publication Publication Date Title
US8372847B2 (en) Pyrazinone modulator of corticotropin-releasing factor receptor activity
JP5439169B2 (ja) 三置換1,2,4−トリアゾール
JP5636434B2 (ja) アルファ7正のアロステリックモジュレーターとしてのモルホリノチアゾール
KR102531689B1 (ko) 6,7―디히드로피라졸로[1,5―α]피라진―4(5H)―온 화합물 및 MGLUR2 수용체의 음성 알로스테릭 조절제로서의 그 용도
JP2020503374A (ja) Bcl6阻害剤としての新規の6−アミノキノリノン化合物および誘導体
KR20030036678A (ko) Gabaa 수용체의 리간드로서의 헤테로사이클릭 화합물
EP2491024B1 (en) Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines
JP2009503069A (ja) 三環式ベンゾイミダゾール類、および代謝性グルタミン酸塩受容体のモジュレータとしてのそれらの使用
JP2010505842A (ja) トロンビン受容体拮抗薬としての二環式誘導体および三環式誘導体
KR102531693B1 (ko) 6,7―디히드로피라졸로[1,5―a]피라진―4(5H)―온 화합물 및 MGLUR2 수용체의 음성 알로스테릭 조절제로서의 그 용도
JP5331002B2 (ja) Cb1受容体モジュレーターとしての1,5−ジフェニル−3−ベンジルアミノ−1,5−ジヒドロピロリジン−2−オン
EP2307410A1 (en) Aza-beta-carbolines and methods of using same
CN102123998A (zh) 作为nk3拮抗剂的异喹啉酮衍生物
JP2011513326A (ja) 疼痛症候群および他の障害の治療法
JP2011529899A (ja) 副腎皮質刺激ホルモン放出因子受容体活性のモジュレーターとしての置換カルバメート誘導体
US6861529B2 (en) Cycloalkypyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives
JP2006525309A (ja) ピロロ(1,2−b)ピリダジン化合物、ならびにCRF−1受容体拮抗薬としてのその使用
CN104718191A (zh) 作为mglur5受体活性调节剂的乙炔基衍生物
SK113399A3 (en) Quinoxalinediones
US20040209887A1 (en) Pyrrolo[1,2-B]pyridazine compounds and their uses
JP2006514628A (ja) Crf変調剤としてのピラジン化合物
US20040204415A1 (en) Pyrrolo[1,2-B]pyridazine compounds and their uses
US20070224636A1 (en) Pyrrolo[1,2b]pyridazine compounds and their uses
CN105431146A (zh) 2-卤代-5-炔基-吡啶基烟碱性配体
US20060166998A1 (en) Pyrrolo[1,2-B]pyridazine compounds and their uses

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20110128

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid